| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |